Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Healthcare & Medical Investment (TSE:3455) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Healthcare & Medical Investment's EV-to-EBIT for today is
Healthcare & Medical Investment's current Enterprise Value is 円81,937 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Healthcare & Medical Investment's EBIT for the trailing twelve months (TTM) ended in Jan. 2026 was 円2,507 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Healthcare & Medical Investment's EV-to-EBITDA for today is:
Healthcare & Medical Investment's current Enterprise Value is 円81,937 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Healthcare & Medical Investment's EBITDA for the trailing twelve months (TTM) ended in Jan. 2026 was 円3,730 Mil.
Healthcare & Medical Investment's current Enterprise Value is 円81,937 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Healthcare & Medical Investment's Revenue for the trailing twelve months (TTM) ended in Jan. 2026 was 円5,176 Mil.
Healthcare & Medical Investment's current Enterprise Value is 円81,937 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Healthcare & Medical Investment's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jan. 2026 was 円3,420 Mil.
Healthcare & Medical Investment's current Enterprise Value is 円81,937 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Healthcare & Medical Investment's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2026 was 円-991 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthcare & Medical Investment Enterprise Value Related Terms
Healthcare & Medical Investment Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthcare & Medical Investment Enterprise Value Chart
TSE:3455 vs WELL, VTR, OHI: Enterprise Value Comparison
For the REIT - Healthcare Facilities subindustry, Healthcare & Medical Investment's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthcare & Medical Investment Enterprise Value vs REITs Industry
For the REITs industry and Real Estate sector, Healthcare & Medical Investment's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Healthcare & Medical Investment's Enterprise Value falls into.
Healthcare & Medical Investment Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthcare & Medical Investment (TSE:3455) has a Enterprise Value of 円81,937 Mil as of Aug. 01, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Healthcare & Medical Investment and its competitors.
Is Healthcare & Medical Investment's Enterprise Value too high?
Healthcare & Medical Investment's current Enterprise Value is 円81,937 Mil. Overall, Healthcare & Medical Investment has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthcare & Medical Investment's Enterprise Value compare to WELL and VTR?
Healthcare & Medical Investment's Enterprise Value of 円81,937 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a REITs company?
A good Enterprise Value depends on the REITs industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Healthcare & Medical Investment and its competitors. Healthcare & Medical Investment's current Enterprise Value is 円81,937 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthcare & Medical Investment stock overvalued right now?
Based on GuruFocus' analysis, Healthcare & Medical Investment (TSE:3455) is currently considered Modestly Undervalued. The stock's GF Value™ is 円129,254.71, compared to a current price of 円105,400.00 — trading 18.5% below its estimated fair value. The current Enterprise Value is 円81,937 Mil. Healthcare & Medical Investment's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Healthcare & Medical Investment (TSE:3455), the current Enterprise Value is 円81,937 Mil as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthcare & Medical Investment (TSE:3455) Overvalued in 2026?
Based on GuruFocus' analysis, Healthcare & Medical Investment stock appears to be undervalued.
The current stock price of 円105,400.00 is trading 18.5% below its estimated GF Value™ of 円129,254.71.
GuruFocus considers Healthcare & Medical Investment to be Modestly Undervalued.
Key valuation signals for TSE:3455:
Enterprise Value: 円81,937 Mil
GF Value™: 円129,254.71 vs. price of 円105,400.00 (18.5% below fair value)
No single metric tells the full story. See the TSE:3455 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthcare & Medical Investment Corp is an investment company, which invests in nursing homes facilities and medical related real properties. The company aims to achieve stable earnings from mid- to long-term perspectives through investment in real estate and other related assets. The firm primarily invests in facilities and buildings for the elderly, as well as medical related facilities.
59GF Score
Get the complete analysis for TSE:3455
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3455 has been successfully added to your 
